Winton Matthewinsider trades

In SEC Form 4 filings, Winton Matthew is listed as Chief Commercial and Business of CervoMed Inc. (CRVO). Winton Matthew reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 23.

Companies and roles

Company	Role	Transactions	Last filed
CRVOCervoMed Inc.	Chief Commercial and Business	1	Oct 23

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-23

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
CRVOCervoMed Inc.	Oct 22	Oct 23	A · derivative	19,100	$2.24	$42,784	19,100	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.